Market Cap (In USD)
335.8 Million
Revenue (In USD)
185.36 Million
Net Income (In USD)
3.31 Million
Avg. Volume
236.11 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.654-8.44
- PE
- -
- EPS
- -
- Beta Value
- 0.944
- ISIN
- US0906831039
- CUSIP
- 090683103
- CIK
- 1819253
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Ms. Teresa S. Weber
- Employee Count
- -
- Website
- https://biote.com
- Ipo Date
- 2021-04-28
- Details
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
More Stocks
-
MRVT
-
GALIMGalimmo SCA
GALIM
-
8905AEON Mall Co., Ltd.
8905
-
EPREPR Properties
EPR
-
PTG
-
001202
-
TEUFFBox Ships Inc.
TEUFF
-
0351